6-K 1 fresenius_6k.htm FORM 6-K

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 6-K

 

REPORT OF FOREIGN PRIVATE ISSUER

 

Pursuant to Rule 13a-16 or 15d-16 of the

Securities Exchange Act of 1934

 

For the month of February 2012

 

FRESENIUS MEDICAL CARE AG & Co. KGaA

(Translation of registrant’s name into English)

 

Else-Kröner Strasse 1

61346 Bad Homburg

Germany

(Address of principal executive offices)

 

    Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.

    Form 20-F     x                                   Form 40-F  o

 

    Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1):  ____

   

    Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7): ____

 

    Indicate by check mark whether the registrant by furnishing the information contained in this Form is also thereby furnishing the information to the Commission pursuant to Rule 12g3-2(b) under the Securities Exchange Act of 1934.

    Yes  o                                   No   x

 

    If “Yes” is marked, indicate below the file number assigned to the registrant in connection with Rule 12g3-2(b): 82

 


 

 

    Attached hereto as Exhibit 99.1 is an Investor News Release issued by Fresenius Medical Care AG & Co. KGaA (the “Company”) on February 24, 2012 announcing that it has filed the annual report 2011 under Form 20-F with the U.S. Securities and Exchange Commission (SEC).

 

EXHIBITS

Exhibit 99.1 Investor News Release issued February 24, 2012.

 


 

 

 

SIGNATURES

 

    Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

 

DATE: February 24, 2012

 

  Fresenius Medical Care AG & Co. KGaA,
  a partnership limited by shares, represented by:
   
  fresenius medical care management ag, its
  general partner
     
  By: /s/ Dr. Ben J. Lipps
    Name: Dr. Ben J. Lipps
    Title:

Chief Executive Officer and Chairman of the Management Board of the General Partner

       
  By: /s/ Michael Brosnan
    Name: Michael Brosnan
    Title: Chief Financial Officer and Member of the Management Board of the General Partner